Safety and efficacy of glivec prior to allografting for CML and Ph-positive ALL: European experience

被引：0
|
作者：
Deininger, MWN
Schleuning, M
Olavarria, E
Fischer, T
Nagler, A
Sayer, H
Boque, C
Volin, L
Piotelli, G
Russel, N
Wandt, H
Schanz, U
Greinix, H
Sponk, L
Sponk
Verdonck, L
Lennard, A
Wimmer, M
Hegenbart, U
Lange, T
Niederwieser, D
机构：
来源：
BONE MARROW TRANSPLANTATION | 2002年 / 29卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
183
引用
收藏
页码：S31 / S31
页数：1
相关论文
共 50 条
  • [1] Ponatinib: hope for patients with CML or Ph-positive ALL?
    Yaqub, Farhat
    LANCET ONCOLOGY, 2013, 14 (13): : E588 - E588
  • [2] Intensive treatment in order to minimize the Ph-positive clone in CML
    Simonsson, B
    Oberg, G
    Bjoreman, M
    Bjorkholm, M
    Carneskog, J
    Gahrton, G
    Hast, R
    Karl, H
    LanngNielsen, J
    Lofvenberg, E
    Malm, C
    Turesson, I
    Uden, AM
    Vilen, L
    WeisBjerrum, O
    BONE MARROW TRANSPLANTATION, 1996, 17 : S63 - S64
  • [3] Dasatinib-Blinatumomab for Ph-Positive ALL
    Foa, Robin
    Chiaretti, Sabina
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (04): : 384 - 384
  • [4] Intensive treatment in order to minimize the Ph-positive clone in CML.
    Simonsson, B
    Oberg, G
    Linder, O
    Bjorkholm, M
    Carneskog, J
    Stenke, L
    Karle, H
    LanngNielsen, J
    Lofvenberg, E
    Malm, C
    Paul, C
    Turesson, I
    Uden, AM
    Vilen, L
    WeisBjerrum, O
    BLOOD, 1997, 90 (10) : 1744 - 1744
  • [5] SECONDARY PH-POSITIVE CML WITH A MINORITY MONOSOMY-7 CLONE
    AUERBACH, HE
    STELMACH, T
    LAGUETTE, JG
    GLICK, JH
    KANT, JA
    NOWELL, PC
    CANCER GENETICS AND CYTOGENETICS, 1987, 28 (01) : 173 - 178
  • [6] CONSTITUTIONAL ROBERTSONIAN T(15-22) IN PH-POSITIVE CML
    BECHER, R
    WENDT, F
    KUHN, D
    HUMAN GENETICS, 1987, 76 (04) : 399 - 399
  • [7] PERSISTENCE OF RECIPIENT CELLS AFTER SYNGENEIC BMT OF PH-POSITIVE CML
    BECHER, R
    SCHAEFER, UW
    MAHMOUD, HK
    SCHMIDT, CG
    BLUT, 1987, 54 (05): : 317 - 318
  • [8] Efficacy and safety of low dose ponatinib in a case of Ph-positive acute lymphoblastic leukaemia
    Marchesi, Francesco
    Salvatorelli, Emanuela
    Renzi, Daniela
    Mengarelli, Andrea
    Minotti, Giorgio
    Menna, Pierantonio
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 187 (01) : E15 - +
  • [9] PH-POSITIVE CML IN A FAMILY WITH A CONSTITUTIONAL ROBERTSONIAN TRANSLOCATION 14-15
    BECHER, R
    MAHMOUD, HK
    SCHAEFER, UW
    SCHMIDT, CG
    CANCER GENETICS AND CYTOGENETICS, 1985, 18 (03) : 229 - 234
  • [10] TRANSLOCATION T(3-20) ASSOCIATED WITH THROMBOCYTHEMIA IN PH-POSITIVE CML
    TURCHINI, MF
    TRAVADE, P
    DELAROCQUE, A
    GENEIX, A
    PERISSEL, B
    MALET, P
    CANCER GENETICS AND CYTOGENETICS, 1986, 20 (1-2) : 1 - 4
12345